Efficacy Evaluation of a New Hyaluronan Derivative HYADD® 4-G to Maintain Cartilage Integrity in a Rabbit Model of Osteoarthritis

Cartilage

Volumn 4, Issue 1, 2013, Pages 28-41

  Mainil Varlet, Pierre ^a   Schiavinato, Antonella ^b   Ganster, Murielle Marie ^c  

^a Aginko Research AG   (Switzerland)

^b Fidia Advanced Biopolymers   (Italy)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

cartilage degradation; growth factors; hyaluronan derivative; osteoarthritis; rabbit ACLT

Indexed keywords

HYADD 4G; HYALURONIC ACID DERIVATIVE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT OSTEOGENIC PROTEIN 1; UNCLASSIFIED DRUG; COLLAGEN TYPE 1; COLLAGEN TYPE 2; OSTEOGENIC PROTEIN 1; RECOMBINANT BONE MORPHOGENETIC PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR CRUCIATE LIGAMENT; ARTICLE; CARTILAGE DEGENERATION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FEMUR CONDYLE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; NONHUMAN; OSTEOARTHRITIS; RABBIT; RADIODIAGNOSIS; SCORING SYSTEM; SYNOVIUM; UPREGULATION; X RAY ANALYSIS; ADULT; ARTICULAR CARTILAGE; HISTOLOGY; KNEE; MANKIN SCORE; MORPHOLOGY; SYNOVIAL MEMBRANE SCORING SYSTEM;

EID: 84871112072     PISSN: 19476035     EISSN: 19476043     Source Type: Journal    
DOI: 10.1177/1947603512455193     Document Type: Article

References (44)

1. Balazs EA,Denlinger JL.Viscosupplementation: a new concept in the treatment of osteoarthritis.J Rheumatol Suppl. 1993;39:3-9.
2. Balazs EADisorders of the knee. Helfet A, ed. Philadelphia: J. B. Lippincott; 1982:61-74.
3. Balazs EA,Denlinger JL.Clinical uses of hyaluronan.Ciba Found Symp. 1989;143:265-75.
4. Altman RD.Intra-articular sodium hyaluronate in osteoarthritis of the knee.Semin Arthritis Rheum. 2000;2:11-8.
5. Adams METhe chemistry, biology and medical applications of hyaluronan and its derivatives. Laurent T, ed. London: Portland Press; 1996:243-53.
6. Weiss CHyaluronan. Kennedy JFPhillips GOWilliams PAHascall VC, ed. Cambridge: Woodhead; 2002:467-82.
7. Balazs EA.Analgesic effect of elastoviscous hyaluronan solutions and the treatment of arthritic pain.Cells Tissues Organs. 2003;174:49-62.
8. Peyron JG,Balazs EA.Preliminary clinical assessment of Na-hyaluronate injection into human arthritic joints.Pathol Biol (Paris). 1974;22:731-6.
9. Bannuru RR,Natov NS,Dasi UR,Schmid CH,McAlindon TE.Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis-meta-analysis.Osteoarthritis Cartilage. 2011;19 (6): 611-9.
10. Moreland LW.Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanism of action.Arthritis Res Ther. 2003;5 (2): 54-67.
11. Ghosh P,Guidolin D.Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent?.Semin Arthritis Rheum. 2002;32:10-37.
12. Altman RD,Moskowitz R.Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial.Hyalgan Study Group. J Rheumatol. 1998;25 (11): 2203-12.
13. Bellamy N,Campbell J,Robinson V,Gee T,Bourne R,Wells G.Viscosupplementation for the treatment of osteoarthritis of the knee.Cochrane Database Syst Rev. 2006; (2): CD005321.
14. Borzacchiello A,Mayol L,Schiavinato A,Ambrosio L.Effect of hyaluronic acid amide derivative on equine synovial fluid viscoelasticity.J Biomed Mater Res A. 2010;92 (3): 1162-70.
15. Smith MM,Cake MA,Ghosh P,Schiavinato A,Read RA,Little CB.Significant synovial pathology in a meniscectomy model of osteoarthritis: modifications by intra-articular hyaluronan therapy.Rheumatology (Oxford). 2008;47 (8): 1172-8.
16. Cake MA,Read R,Edwards S,Smith MM,Burkardt D,Little C, et al.Changes in gait after bilateral meniscectomy in sheep: effect of two hyaluronan preparations.J Orthop Sci. 2008;13 (6): 514-23.
17. Nishida Y,Knudson CB,Kuettner KE,Knudson W.Osteogenic protein-1 promotes the synthesis and retention of extracellular matrix within bovine articular cartilage and chondrocyte cultures.Osteoarthritis Cartilage. 2000;8:127-36.
18. Nishida Y,Knudson CB,Eger W,Kuettner KE,Knudson W.Osteogenic protein-1 stimulates cell-associated matrix assembly by normal human articular chondrocytes.Arthritis Rheum. 2000;43:206-14.
19. Flechtenmacher J,Huch K,Thonar EJMA,Mollenhauer J,Davies SR,Schmid TM, et al.Recombinant human osteogenic protein 1 is a potent stimulator of the synthesis of cartilage proteoglycans and collagens by human articular chondrocytes. Arthritis Rheum. 1996;39:478-88.
20. Amiel D,Toyoguchi T,Kobayashi K,Bowden K,Amiel ME,Healey RM.Long-term effect of sodium hyaluronate (Hyalgan) on osteoarthritis progression in a rabbit model.Osteoarthritis Cartilage. 2003;11 (9): 636-43.
21. Ozlem Nisbet H,Ozak A,Yardimci C,Nisbet C,Yarim M,Bayrak IK, et al.Evaluation of bee venom and hyaluronic acid in the intra-articular treatment of osteoarthritis in an experimental rabbit model. Res Vet Sci. 2012;93 (1): 488-93.
22. Rijk PC,de Rooy TP,Coerkamp EG,Bernoski FP,van Noorden CJ.Radiographic evaluation of the knee joint after meniscal allograft transplantation. An experimental study in rabbits.Knee Surg Sports Traumatol Arthrosc. 2002;10:241-6.
23. Outerbridge RE.The etiology of chondromalacia patellae.J Bone Joint Surg Br. 1962;43:752-7.
24. Mankin HJ,Dorfman H,Lippiello L.Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II Correlation of morphology with biochemical and metabolic data.J Bone Joint Surg Am. 1971;53 (3): 523-37.
25. Cake MA,Smith MM,Young AA,Ghosh P,Read RA.Synovial pathology in an ovine model of osteoarthristis: effect of intraarticular hyaluronan (Hyalgan).Clin Exp Rheumatol. 2008;26 (4): 561-7.
26. Giovannini S,Diaz-Romero J,Aigner T,Mainil-Varlet P,Nesic D.Population doublings and percentage of S100-positive cells as predictors of in vitro chondrogenicity of expanded human articular chondrocytes.J Cell Physiol. 2010;222 (2): 411-20.
27. Pozo MA,Balazs EA,Belmonte C.Reduction of sensory responses to passive movements of inflamed knee joints by hylan, a hyaluronan derivative.Exp Brain Res. 1997;116:3-9.
28. Pawlak MHyaluronan. Kennedy JFPhillips GOWilliams PAHascall VC, ed. Cambridge: Woodhead; 2002:341-52.
29. Gomis A,Pawlak M,Balazs EA,Schmidt RF,Belmonte C.Effects of different molecular weight elastoviscous hyaluronan solutions on articular nociceptive afferents.Arthritis Rheum. 2004;50 (1): 314-26.
30. Gomis A,Miralles A,Schmidt RF,Belmonte C.Nociceptive nerve activity in an experimental model of knee joint osteoarthritis of the guinea pig: effect of intra-articular hyaluronan application.Pain. 2007;130:126-36.
31. Belmonte C,Pozo MA,Balazs EAThe chemistry, biology and medical applications of hyaluronan and its derivatives. Laurent TC, ed. London: Portland Press; 1998:205-17.
32. Prestwich GD,Kuo JW.Chemically modified HA for therapy and regenerative medicine.Curr Pharm Biotechnol. 2008;9 (4): 242-5.
33. Gomis A,Miralles A,Schmidt RF,Belmonte C.Intra-articular injections of hyaluronan solutions of different elastoviscosity reduce nociceptive nerve activity in a model of osteoarthritic knee joint of the guinea pig.Osteoarthritis Cartilage. 2009;17 (6): 798-804.
34. Chevalier X,Jerosch J,Goupille P,van Dijk N,Luyten FP,Scott DL, et al.Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomized, multicentre, double-blind, placebo controlled trial.Ann Rheum Dis. 2010;69 (1): 113-9.
35. Julovi SM,Ito H,Nishitani K,Jackson CJ,Nakanura T.Hyaluronan inhibits matrix metalloproteinase-13 in human arthritic chondrocytes via CD44 and P38.J Orthop Res. 2011;29 (2): 258-64.
36. Ohno S,Im HJ,Knudson CB,Knudson W.Hyaluronan oligosaccharides induce matrix metalloproteinase 13 via transcriptional activation of NFkappaB and p38MAP kinase in articular chondrocytes.J Biol Chem. 2006;281 (26): 17952-60.
37. Goldberg VM,Buckwalter JA.Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity.Osteoarthritis Cartilage. 2005;13:216-24.
38. Rogachefsky RA,Dean DD,Howell DS,Altman RD.Treatment of canine osteoarthritis with insulin-like growth factor-1 (IGF-1) and sodium pentosan polysulfate.Osteoarthritis Cartilage. 1993;1 (2): 105-14.
39. Hunter DJ,Picke MC,Jonas BL,Kissin E,Krop J,McAlindon T.Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritis.BMC Musculoskelet Disord. 2010;11:232.
40. Badlani N,Inoue A,Healey R,Coutts R,Amiel D.The protective effect of OP-1 on articular cartilage in the development of osteoarthritis.Osteoarthritis Cartilage. 2008;16 (5): 600-6.
41. Badlani N,Oshima Y,Healey R,Coutts R,Amiel D.Use of morphogenic protein-7 as a treatment for osteoarthritis.Clin Orthop Relat Res. 2009;467 (12): 3221-9.
42. Hayashi M,Muneta T,Takahashi T,Ju YI,Tsuji K,Sekiya I.Intra-articular injections of bone morphogenetic protein-7 retard progression of existing cartilage degeneration.Orthop Res. 2010;28 (11): 1502-6.
43. Loeser RF,Shanker RG,Carlson CS,Gardin JF,Shelton BJ,Sonntag WE.Reduction in the chondrocyte response to insulin-like growth factor 1 in aging and osteoarthritis: studies in a non human primate model of naturally occurring disease.Arthritis Rheum. 2000;43 (9): 1916-26.
44. Andhare RA,Takahashi N,Knudson W,Knudson CB.Hyaluronan promotes the chondrocyte response to BMP-7.Osteoarthritis Cartilage. 2009;17 (7): 906-16.